• RTS,S is the most promising malaria vaccine candidate to date. Results of the RTS,S trial have reinvigorated the field of malaria research and development and helped demonstrate that an effective malaria vaccine is indeed possible.
  
  
• MVI manages 14 projects in addition to RTS,S. It is critical to work on multiple vaccine candidates, no matter how promising the data on RTS,S. The vaccine could fail in subsequent trials, or there may be another vaccine that would prevent more disease. It is particularly important to manage a stream of activities because the most effective vaccine may involve a combination of candidates or even another scientific or technical approach.

Next: Key Lessons